GGrantIndex
Sort

17,288 grants matching multiple sclerosis

Novel Hsp90 Inhibitors: Proof-of-Principle for Treatment of Motor Neuron Diseases

$177,720
Ruihong Chen · Nexgenix Pharmaceuticals, Inc. · R21 · FY2010 · NS

Cre, Dre Dual Lineage Model for Calcium Imaging and Optogenetic Manipulations

$177,718
Petr Tvrdik · University Of Utah · R21 · FY2014 · OD

The Role of Telomerase in Oligodendrocyte Proliferation

$177,642
Gregg L Caporaso · Weill Medical Coll Of Cornell Univ · K02 · FY2006 · NS

Neuronal Expression of Hemoglobin in Multiple Sclerosis Cortex

$177,560
Jennifer McDonough · Kent State University · R21 · FY2013 · NS

Mass Spectrometry, Proteomics and Metabolomics Core

$177,382
John M Asara · Brigham And Women'S Hospital · P01 · FY2014 · CA

THE PGRN/TDP-43 AXIS IN ALZHEIMER?S DISEASE AND NEURODEGENERATION

$177,293
Rosa Rademakers · Mayo Clinic Rochester · P50 · FY2010 · AG

Novel modulation of dendritic cell response against a chronic virus infection

$177,284
Bumsuk Hahm · University Of Missouri-Columbia · R21 · FY2011 · AI

mTOR-containing Protein Complexes in the Pathogenesis of Tuberous Sclerosis

$177,240
Arnold Kristof · Mcgill University · R01 · FY2008 · CA

Core D - Neuropathology, Genetics, and Biomarker Core

$177,199
John Q. Trojanowski · University Of Pennsylvania · P30 · FY2019 · AG

CTL ESCAPE MUTANTS AND MHV-INDUCED DEMYELINATION

$177,153
University Of Iowa · R01 · FY2000 · NS

UAB Pre and Post-Doctoral Training Program in Biostatistics

$177,151
Gary R Cutter · University Of Alabama At Birmingham · T32 · FY2009 · NS

Tissue Imaging Using Desorption Electrospray Ionization Mass Spectrometry

$177,129
Robert Graham Cooks · Purdue University · R21 · FY2010 · EB

Cognitive-Motor Interference Assessment for Improving Neurologic and Physical Disability Outcomes (CAMINANDO) in Survivors of Severe Acute Respiratory Failure

$177,120
Aluko A. Hope · Albert Einstein College Of Medicine · K01 · FY2019 · HL

Zinc finger nuclease induced knockout and knock-in models in zebrafish

$177,074
Meera T Saxena · Luminomics, Inc. · R43 · FY2011 · MH

Vitamin D, cigarette smoking, EBV infection and risk of MS progression

$177,039
Alberto Ascherio · Harvard School Of Public Health · R01 · FY2013 · NS

High throughput assay for fibrin-binding probes

$177,000
Peter D Caravan · Massachusetts General Hospital · R21 · FY2011 · NS

Fast Whole-Brain Direct Myelin Magnetic Resonance Imaging

$176,875
Victor Andrew Stenger · University Of Hawaii At Manoa · R21 · FY2017 · EB

Computer-Assisted Cognitive Rehabilitation Intervention for Persons with MS

$176,873
Alexa K Stuifbergen · University Of Texas At Austin · R21 · FY2010 · NR

ROLE OF T CELLS IN THE IMMUNE MODULATION OF MS

$176,824
Nitin J Karandikar · Ut Southwestern Medical Center · R01 · FY2009 · AI

OLIGODENDROCYTE GENERATION--A MULTIFACTORIAL APPROACH

$176,708
Pennsylvania State Univ Hershey Med Ctr · R01 · FY2002 · NS

Cognitive-Motor Interference Assessment for Improving Neurologic and Physical Disability Outcomes (CAMINANDO) in Survivors of Severe Acute Respiratory Failure

$176,580
Aluko A. Hope · Albert Einstein College Of Medicine · K01 · FY2021 · HL

Cognitive-Motor Interference Assessment for Improving Neurologic and Physical Disability Outcomes (CAMINANDO) in Survivors of Severe Acute Respiratory Failure

$176,580
Aluko A. Hope · Albert Einstein College Of Medicine · K01 · FY2020 · HL

Cognitive Motor Interference Assessment for Improving Neurologic and Physical Disability Outcomes in Survivors of Severe Acute Respiratory Failure (CAMINANDO) Phase II

$176,580
Aluko A. Hope · Oregon Health & Science University · K01 · FY2022 · HL

Recombinant siRNA Carriers for Targeted Delivery across the Blood Brain Barrier

$176,510
Darin Yale Furgeson · University Of Utah · R21 · FY2009 · NS

Impact on Reproductive Aging on Neural-Immune Responses

$176,493
Farida Sohrabji · Texas A&M University Health Science Ctr · R01 · FY2006 · AG